RYPNX vs. NSVAX

Last updated Jul 16, 2026

RYPNX (Royce Opportunity Fund) and NSVAX (Columbia Small Cap Value Fund II) are both Small Cap Value Equities funds. Over the past 10 years, RYPNX returned 14.42%/yr vs 10.69%/yr for NSVAX. With a 0.95 correlation, they move nearly in lockstep. RYPNX charges 1.21%/yr vs 1.02%/yr for NSVAX.

Performance

RYPNX vs. NSVAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Royce Opportunity Fund (RYPNX) and Columbia Small Cap Value Fund II (NSVAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RYPNX achieves a 29.76% return, which is significantly higher than NSVAX's 24.19% return. Over the past 10 years, RYPNX has outperformed NSVAX with an annualized return of 14.42%, while NSVAX has yielded a comparatively lower 10.69% annualized return.

RYPNX

• 1D: 1.08%
• 1M: -1.01%
• 6M: 20.00%
• YTD: 29.76%
• 1Y: 47.17%
• 3Y*: 18.88%
• 5Y*: 10.50%
• 10Y*: 14.42%

NSVAX

• 1D: 0.13%
• 1M: 1.97%
• 6M: 18.43%
• YTD: 24.19%
• 1Y: 37.73%
• 3Y*: 16.77%
• 5Y*: 10.11%
• 10Y*: 10.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RYPNX vs. NSVAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RYPNX Royce Opportunity Fund	29.76%	11.95%	10.20%	19.72%	-17.19%	30.34%	26.52%	28.24%	-20.10%	21.69%
NSVAX Columbia Small Cap Value Fund II	24.19%	8.20%	11.25%	14.10%	-13.70%	34.27%	10.11%	20.65%	-17.48%	10.46%

Correlation

The correlation between RYPNX and NSVAX is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.88
Correlation (3Y) Calculated over the trailing 3-year period	0.90
Correlation (5Y) Calculated over the trailing 5-year period	0.93
Correlation (10Y) Calculated over the trailing 10-year period	0.94
Correlation (All Time) Calculated using the full available price history since May 1, 2002	0.95

The correlation between RYPNX and NSVAX has been stable across timeframes, ranging from 0.88 to 0.95 - a consistent structural relationship.

Return for Risk

RYPNX vs. NSVAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RYPNX

RYPNX Risk / Return Rank: 81
RYPNX Sharpe Ratio Rank: 79
RYPNX Sortino Ratio Rank: 75
RYPNX Omega Ratio Rank: 69
RYPNX Calmar Ratio Rank: 91
RYPNX Martin Ratio Rank: 91

NSVAX

NSVAX Risk / Return Rank: 83
NSVAX Sharpe Ratio Rank: 81
NSVAX Sortino Ratio Rank: 81
NSVAX Omega Ratio Rank: 76
NSVAX Calmar Ratio Rank: 91
NSVAX Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RYPNX vs. NSVAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Royce Opportunity Fund (RYPNX) and Columbia Small Cap Value Fund II (NSVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RYPNX	NSVAX	Difference
Sharpe ratio: Return per unit of total volatility	2.04	2.09	-0.05
Sortino ratio: Return per unit of downside risk	2.77	3.05	-0.28
Omega ratio: Gain probability vs. loss probability	1.34	1.37	-0.03
Calmar ratio: Return relative to maximum drawdown	3.74	3.72	+0.02
Martin ratio: Return relative to average drawdown	13.98	13.12	+0.86

RYPNX vs. NSVAX - Sharpe Ratio Comparison

The current RYPNX Sharpe Ratio is 2.04, which is comparable to the NSVAX Sharpe Ratio of 2.09. The chart below compares the historical Sharpe Ratios of RYPNX and NSVAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RYPNX vs. NSVAX - Drawdown Comparison

The maximum RYPNX drawdown since its inception was -69.31%, which is greater than NSVAX's maximum drawdown of -59.32%. Use the drawdown chart below to compare losses from any high point for RYPNX and NSVAX.

Drawdown Indicators

	RYPNX	NSVAX	Difference
Max Drawdown Largest peak-to-trough decline	-69.31%	-59.32%	-9.99%
Max Drawdown (1Y) Largest decline over 1 year	-12.01%	-9.51%	-2.50%
Max Drawdown (3Y) Largest decline over 3 years	-30.23%	-27.11%	-3.12%
Max Drawdown (5Y) Largest decline over 5 years	-30.77%	-27.11%	-3.66%
Max Drawdown (10Y) Largest decline over 10 years	-50.61%	-48.33%	-2.28%
Current Drawdown Current decline from peak	-3.11%	-0.63%	-2.48%
Average Drawdown Average peak-to-trough decline	-10.64%	-9.69%	-0.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.21%	2.70%	+0.51%

Volatility

RYPNX vs. NSVAX - Volatility Comparison

Royce Opportunity Fund (RYPNX) has a higher volatility of 5.05% compared to Columbia Small Cap Value Fund II (NSVAX) at 3.73%. This indicates that RYPNX's price experiences larger fluctuations and is considered to be riskier than NSVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RYPNX	NSVAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.05%	3.73%	+1.32%
Volatility (6M) Calculated over the trailing 6-month period	15.60%	11.94%	+3.66%
Volatility (1Y) Calculated over the trailing 1-year period	22.06%	16.96%	+5.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.32%	22.30%	+2.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.30%	23.82%	+1.48%

RYPNX vs. NSVAX - Expense Ratio Comparison

RYPNX has a 1.21% expense ratio, which is higher than NSVAX's 1.02% expense ratio.

Dividends

RYPNX vs. NSVAX - Dividend Comparison

RYPNX's dividend yield for the trailing twelve months is around 7.42%, less than NSVAX's 15.08% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NSVAX Columbia Small Cap Value Fund II	15.08%	15.89%	29.38%	6.93%	6.46%	13.95%	0.83%	3.68%	14.97%	9.10%	5.23%	12.66%
RYPNX Royce Opportunity Fund	7.42%	9.63%	7.95%	4.52%	5.12%	22.51%	0.00%	1.57%	10.21%	14.91%	6.89%	10.04%

Frequently Asked Questions

Can I hold both RYPNX and NSVAX in my portfolio?

RYPNX and NSVAX have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RYPNX or NSVAX?

RYPNX has higher volatility (5.05%) compared to NSVAX (3.73%). In terms of maximum drawdown, RYPNX dropped -69.31% vs NSVAX's -59.32%.

Which has better risk-adjusted returns?

NSVAX currently has the higher Sharpe Ratio (2.09 vs 2.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.